Environmental Surfaces in Healthcare Facilities are a Potential Source for Transmission of Candida auris and Other Candida Species

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Christina T PiedrahitaCurtis J Donskey

Abstract

Contaminated surfaces have been implicated as a potential route for dissemination of the emerging multidrug-resistant fungal pathogen Candida auris. In laboratory testing, C. auris and other Candida species persisted for 7 days on moist or dry surfaces. Candida species were recovered frequently from the hospital environment, particularly from moist surfaces. Infect Control Hosp Epidemiol 2017;38:1107-1109.

References

May 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M A Pfaller
Aug 18, 2006·BMC Infectious Diseases·Axel KramerGünter Kampf
Jul 28, 2016·The Journal of Infection·Belinda CalvoArnaldo Lopes Colombo
Nov 25, 2016·Journal of Clinical Microbiology·Masako MizusawaSean X Zhang
Dec 29, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S VallabhaneniT M Chiller
Jun 9, 2017·Journal of Occupational and Environmental Medicine·Jason LangJoel Hampton

❮ Previous
Next ❯

Citations

Jan 27, 2018·Journal of Fungi·Ryan KeanGordon Ramage
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Annette L JencsonCurtis J Donskey
Nov 17, 2017·Clinical Microbiology Reviews·Anna Jeffery-SmithColin S Brown
May 23, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Patricia EscandónTom M Chiller
Oct 4, 2018·The New England Journal of Medicine·David W EyreKatie J M Jeffery
Sep 21, 2018·Journal of Clinical Microbiology·D Joseph SextonAnastasia P Litvintseva
Dec 12, 2018·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Scott A GestrichCurtis J Donskey
Feb 16, 2019·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·William A RutalaDavid J Weber
Feb 1, 2018·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Anubhav KanwarCurtis J Donskey
Aug 11, 2017·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jennifer L CadnumCurtis J Donskey
May 23, 2019·Journal of Occupational and Environmental Hygiene·Steven R TorresMagdia De Jesus
Feb 19, 2019·Mycoses·Shabir A Lone, Aijaz Ahmad
Jul 5, 2019·Journal of Medical Microbiology·David RomeraJaime Esteban
Oct 28, 2019·Journal of Fungi·Amal Al MaaniAbdullah M S Al-Hatmi
Jun 7, 2019·Archives of Pathology & Laboratory Medicine·D Jane HataUNKNOWN College of American Pathologists Microbiology Committee
Dec 6, 2019·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Lucas D JonesCurtis J Donskey
Jan 10, 2020·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Shannon A NovosadDavid Kuhar
Mar 1, 2020·Journal of Fungi·Ryan KeanGordon Ramage
Apr 3, 2020·Expert Review of Anti-infective Therapy·Arunaloke Chakrabarti, Shreya Singh
Aug 21, 2019·Antimicrobial Agents and Chemotherapy·Nathan P WiederholdThomas F Patterson
Jan 10, 2018·Antimicrobial Agents and Chemotherapy·Christopher L HagerMahmoud A Ghannoum
Apr 16, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Massimo PacilliStephanie R Black
Jun 21, 2019·BMC Infectious Diseases·Caroline MasloJennifer Coetzee
Apr 17, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Amira ElBaradei
Aug 20, 2019·Internal Medicine Journal·Chong W OngUNKNOWN Australian and New Zealand Mycoses Interest Group (ANZMIG); and the Healthcare Infection Control Special Interest Group (HIC
Dec 19, 2019·Frontiers in Microbiology·Farid ChaabaneAlix T Coste
Aug 8, 2018·Medical Mycology·Kaitlin ForsbergSnigdha Vallabhaneni
Dec 24, 2018·Materials·Katarzyna Ledwoch, Jean-Yves Maillard
May 3, 2019·Current Infectious Disease Reports·Graham M Snyder, Sharon B Wright
Sep 3, 2020·Antibiotics·Juan V Mulet BayonaConcepción Gimeno Cardona
Feb 2, 2018·The Journal of Infectious Diseases·Frederic Lamoth, Dimitrios P Kontoyiannis
Aug 11, 2018·Food and Environmental Virology·Cheonghoon LeeGwangPyo Ko
Jan 12, 2019·Frontiers in Microbiology·Luana Rossato, Arnaldo Lopes Colombo
May 1, 2018·Frontiers in Microbiology·Tsun S N KuSamuel A Lee
Aug 24, 2019·Emerging Infectious Diseases·Erika van SchalkwykUNKNOWN GERMS-SA

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Sreelatha KogantiCurtis J Donskey
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Jason S BiswasSimon D Goldenberg
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Lindsey M WeinerAlexander J Kallen
© 2021 Meta ULC. All rights reserved